Casa asdas

Disease Control Data, nr-axSpA

Por um escritor misterioso

Last updated 13 abril 2025

Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.

Understanding differences between men and women with axial spondyloarthritis - ScienceDirect

Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis

Women experience higher axial spondyloarthritis disease burden than men

Reviewing Disease Activity Indices in Spondyloarthritis From the Sex Perspective: A Systematic Review and Metaanalysis

FDA Approval Of The First nr-AxSpA Biologics Projecting Regulatory Market Dynamics

Maybe It's NOT Mechanical Back Pain : Clinical Resource

Gender Differences in Baseline Clinical Characteristics Among Patients with Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis: Data from 3 Randomized Ixekizumab Controlled Trials - ACR Meeting Abstracts

Building a Treatment Plan for active Non-radiographic Axial Spondyloarthritis (nr-axSpA)

Treatment Efficacy, nr-axSpA, Rheumatology

Study flow diagram. axSpA: axial spondyloarthritis; TNF-α: tumor

Non-Radiographic Axial Spondyloarthritis: Symptoms of Inflammatory Back Pain

The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis

A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy

Recomendado para você